ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 13,000 full-time employees. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
Mr. Vivek Jain 2014 'den beri şirketle birlikte olan ICU Medical Inc 'in Chairman of the Board 'ıdır.
ICUI hissesinin fiyat performansı nasıl?
ICUI 'in mevcut fiyatı $126.24 'dir, son işlem günde 0.7% arttırılmış etti.
ICU Medical Inc için ana iş temaları veya sektörler nelerdir?
ICU Medical Inc Health Care endüstrisine ait ve sektör Health Care 'dir
ICU Medical Inc 'in piyasa değerlemesi nedir?
ICU Medical Inc 'in mevcut piyasa değerlemesi $3.1B 'dir
ICU Medical Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 7 analist ICU Medical Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 4 güçlü al, 6 al, 2 tut, 0 sat ve 4 güçlü sat içermektedir